title: Prevalence and persistence of nonnucleoside reverse transcriptase inhibitor mutations in the female genital tract.
authors.forename: Michael
authors.initials: M
authors.lastname: Newstein
authors.forename: Phyllis
authors.initials: P
authors.lastname: Losikoff
authors.forename: Angela
authors.initials: A
authors.lastname: Caliendo
authors.forename: Jessica
authors.initials: J
authors.lastname: Ingersoll
authors.forename: Jaclynn
authors.initials: J
authors.lastname: Kurpewski
authors.forename: Dawn
authors.initials: D
authors.lastname: Hanley
authors.forename: Joselyn
authors.initials: J
authors.lastname: Cerezo
authors.forename: Bharat
authors.initials: B
authors.lastname: Ramratnam
authors.forename: Susan
authors.initials: S
authors.lastname: Cu-Uvin
mesh_terms: D019943:Amino Acid Substitution; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D024882:Drug Resistance, Viral / Q000235:genetics*; D005260:Female; D005836:Genitalia, Female / Q000821:virology*; D006678:HIV / Q000187:drug effects* / Q000235:genetics* / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D009154:Mutation; D010949:Plasma / Q000821:virology; D015995:Prevalence; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors